Edition:
United Kingdom

G1 Therapeutics Inc (GTHX.OQ)

GTHX.OQ on NASDAQ Stock Exchange Global Select Market

46.81USD
19 Oct 2018
Change (% chg)

$-0.09 (-0.19%)
Prev Close
$46.90
Open
$46.71
Day's High
$48.41
Day's Low
$46.35
Volume
148,658
Avg. Vol
133,562
52-wk High
$69.23
52-wk Low
$18.45

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Seth Rudnick

69 2017 Independent Chairman of the Board

Mark Velleca

54 2014 President, Chief Executive Officer, Director

Barclay Phillips

55 2017 Chief Financial Officer and Senior Vice President - Corporate Development

Rajesh Malik

59 2018 Chief Medical Officer, Senior Vice President - Research and Development

Terry Murdock

58 2017 Senior Vice President - Development Operations